Indian Journal of Urology Users online:62  
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size

  Table of Contents 
Year : 2017  |  Volume : 33  |  Issue : 2  |  Page : 99-100

What's inside

Department of Urology, Christian Medical College, Vellore, Tamil Nadu, India

Date of Web Publication30-Mar-2017

Correspondence Address:
Arabind Panda
Department of Urology, Christian Medical College, Vellore, Tamil Nadu
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/iju.IJU_96_17

Rights and Permissions


How to cite this article:
Panda A. What's inside. Indian J Urol 2017;33:99-100

How to cite this URL:
Panda A. What's inside. Indian J Urol [serial online] 2017 [cited 2023 Feb 8];33:99-100. Available from:

   Multiparametric Magnetic Resonance Imaging: Transrectal Ultrasound-guided Fusion Biopsy Top

Prostate cancer in India presents late and remains an important cause of death in men. Bansal et al.[1] present data regarding the use of multiparametric-magnetic resonance imaging transrectal ultrasound fusion biopsy in an Indian cohort of patients. Prostate cancer in India may have a different presentation compared to the West, and Indian data can help us further refine our management protocols.

   Penile Urethral Strictures Top

Strictures of the penile urethra are difficult to manage. Skin flaps to grafts have all been used with varying degrees of success. Joshi et al.[2] present a composite two-stage urethroplasty for complex penile strictures without balanitis xerotica obliterans (BXO). The buccal mucosal graft (BMG) was applied in the second stage and immediately tubularized. This is distinct from the commonly performed technique of applying the BMG in the first stage. Despite excluding BXO strictures, the patients included both failed hypospadias repair and other causes of urethral strictures. Residual chordee in the former group will present a challenge, but the concept that immediate tubularization will aid take of the graft due to a moist environment has merit and can improve results.

   Prognosticating and Novel Therapy for Bladder Cancer: the Role of Micro-rnas Top

Recurrent bladder cancer is hypothesized to be a result of field change in the transitional epithelium of the urinary tract. Markers for progression and invasiveness can help us offer management options that are tailored to the individual patient. Mitash et al.[3] review the role of cellular metabolic regulatory molecules, such as micro-RNA, which can be used as biomarkers to prognosticate or as targeted therapy for bladder cancer.

   An Incontinence Activity Participation Scale for Spinal Cord Injury Top

Walia and Kaur [4] present a novel scale to measure the involvement of spinal cord injured (SCI) patients in life situations. Incontinence is a major barrier for increased participation in activities outside their homes. The scale should help urologists quantify the problems of SCI patients and follow up on the success of therapy.

   Extended - Spectrum Beta-lactamase - Producing, Carbapenem-resistant Uropathogens May Be Fosfomycin Sensitive Top

Carbapenem-resistant pathogens have rapidly spread to almost all hospital settings. They remain perhaps the greatest threat to our attempts to control serious nosocomial infections. Banerjee et al.[5] discuss the role of fosfomycin in the treatment of such isolates. However, the translation of in vitro sensitivity into in vivo success and clinical usefulness of this drug remains to be seen.

   Does the Indication for Partial Nephrectomy Affect the Complication and Outcomes? Top

Venkatramani et al.[6] reviewed data to see if the preoperative indications for partial nephrectomy (elective, relative, and absolute) affected the perioperative complications and outcome. The results point to fewer complications in the elective arm.

   Can Sterile Water Irrigation Be a Substitute for Single-dose Mitomycin-c After Transurethral Resection of Bladder Tumors? Top

The use of intravesical mitomycin-C immediately after transurethral resection of bladder tumor is common in an attempt to prevent tumor cell re-implantation and consequent recurrence. In a randomized controlled trial, Bijalwan et al.[7] compared continuous irrigation with sterile water to a single intravesical mitomycin C instillation and detected no significant difference.

   Bladder Cancer: What the Future Holds? Top

While radical cystectomy remains the primary surgery for muscle invasive bladder cancer, the therapy is multimodal. The treatment of advanced bladder cancer has changed over the years with newer chemotherapeutic agents and molecular subtyping of the cancer. This issue has a symposium on muscle invasive bladder cancer guest edited by Kamat [8] which discusses the newer trends in therapy.

   Surgical Management of Muscle Invasive Bladder Cancer Top

Treatment of muscle invasive bladder cancer continues to evolve with ongoing discussions on the use of neoadjuvant chemotherapy, extent of pelvic lymph node dissection, and an attempt on organ preservation. Kukreja and Shah [9] discuss the advances in its surgical management.

   Bladder Preservation in Selected Cases of Muscle Invasive Cancer Top

Radical cystectomy is the gold standard for muscle invasive bladder cancer. Wade-Smelser et al.[10] review the role of bladder preservation in selected cases, indications, and oncological outcomes. The quality of life after such therapy is also discussed.

   Systemic Therapy in Bladder Cancer Top

Neoadjuvant therapy for muscle invasive disease has achieved better survival rates than primary surgery. All patients who may benefit from therapy, however, do not receive it. Pinto [11] discusses the agents used in neoadjuvant and adjuvant settings in muscle invasive disease. The role of second-line immunotherapy is also discussed.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

   References Top

Bansal S, Gupta NP, Yadav R, Khera R, Ahlawat K, Gautam D, et al. Multiparametric magnetic resonance imaging-transrectal ultrasound fusion prostate biopsy: A prospective, single centre study. Indian J Urol 2017;33:134-9.  Back to cited text no. 1
  [Full text]  
Mitash N, Tiwari S, Agnihotri S, Mandhani A. Bladder cancer: Micro RNAs as biomolecules for prognostication and surveillance. Indian J Urol 2017;33:127-3.  Back to cited text no. 2
  [Full text]  
Joshi PM, Barbagli G, Batra V, Surana S, Hamouda A, Sansalone S, et al. Composite two-stage urethroplasty for complex penile strictures: A multicenter experience. Indian J Urol 2017;33:155-8.  Back to cited text no. 3
  [Full text]  
Walia P, Kaur J. Development and validation of incontinence-Activity participation scale (I-APS) for spinal cord injury. Indian J Urol 2017;33159-64.  Back to cited text no. 4
Banerjee S, Sengupta M, Sarker TK. Fosfomycin susceptibility among multidrug resistant, ESBL producing, and carbapenem resistant uropathogens. Indian J Urol 2017;33:149-54.  Back to cited text no. 5
  [Full text]  
Venkatramani V, Kumar S, Chandrasingh J, Devasia A, Kekre NS. Perioperative complications and postoperative outcomes of partial nephrectomy for renal cell carcinoma: Does indication matter? Indian J Urol 2017;33:140-3.  Back to cited text no. 6
  [Full text]  
Bijalwan P, Pooleri GK, Thomas A. comparison of sterile water irrigation vs. intravesical mitomycin C in preventing the recurrence of non-muscle invasive bladder cancer after transurethral resection. Indian J Urol 2017;33:144-8.  Back to cited text no. 7
  [Full text]  
Kamat A. Bladder Cancer: 2017 and beyond. Indian J Urol 2017;33:104-5.  Back to cited text no. 8
  [Full text]  
Kukreja JB, Shah JB. Advances in surgical management of muscle invasive bladder cancer. Indian J Urol 2017;33:106-10.  Back to cited text no. 9
  [Full text]  
Smelser WW, Austenfeld MA, Holzbeierlein JM, Lee EK. Where are we with bladder preservation for muscle-invasive bladder cancer in 2016? Indian J Urol 2017;33:111-7.  Back to cited text no. 10
  [Full text]  
Pinto IG. Systemic therapy in bladder cancer. Indian J Urol 2017;33:118-26.  Back to cited text no. 11
  [Full text]  


Print this article  Email this article


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (321 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

    Multiparametric ...
    Penile Urethral ...
    Prognosticating ...
    An Incontinence ...
    Producing, Carba...
    Does the Indicat...
    Can Sterile Wate...
    Bladder Cancer: ...
    Surgical Managem...
    Bladder Preserva...
    Systemic Therapy...
    Extended - Spect...

 Article Access Statistics
    PDF Downloaded117    
    Comments [Add]    

Recommend this journal